When.com Web Search

  1. Ads

    related to: crestor vs lipitor reviews

Search results

  1. Results From The WOW.Com Content Network
  2. AstraZeneca's Crestor Fails to Best Lipitor in Study - AOL

    www.aol.com/2011/09/02/astrazenecas-crestor...

    AstraZeneca (NYS: AZN) just lost a potential marketing edge for Crestor. In trial results announced today, the statin drug failed to best Lipitor at clearing clogged arteries, at least in a ...

  3. Rosuvastatin - Wikipedia

    en.wikipedia.org/wiki/Rosuvastatin

    Rosuvastatin, sold under the brand name Crestor among others, is a statin medication, used to prevent cardiovascular disease in those at high risk and treat abnormal lipids. [6] It is recommended to be used together with dietary changes, exercise, and weight loss. [ 6 ]

  4. AZ's Crestor Scored Points, but Didn't Beat Lipitor - AOL

    www.aol.com/news/2011-11-15-azs-crestor-scored...

    AstraZeneca's (NYS: ANZ) press release on the SATURN trial is an object lesson in how to spin a study that didn't turn out as expected: Focus on the positive. The company announced SATURN showed ...

  5. Fewer people may need statins to prevent heart disease, new ...

    www.aol.com/news/fewer-people-may-statins...

    Statins, such as Lipitor, Crestor and Zocor, are widely used to protect against high levels of LDL cholesterol, one of the causes of cardiovascular disease. Doctors prescribe the daily pills based ...

  6. Statin - Wikipedia

    en.wikipedia.org/wiki/Statin

    A 2013 Cochrane review found a decrease in risk of death and other poor outcomes without any evidence of harm. [4] For every 138 people treated for 5 years, one fewer dies; for every 49 treated, one fewer has an episode of heart disease. [11] A 2011 review reached similar conclusions, [25] and a 2012 review found benefits in both women and men ...

  7. JUPITER trial - Wikipedia

    en.wikipedia.org/wiki/JUPITER_trial

    JUPITER was a randomized double-blind placebo-controlled study investigating the use of rosuvastatin in the primary prevention of cardiovascular disease.The trial focused on patients with normal low-density lipoprotein (LDL) cholesterol levels but increased levels of high-sensitivity C-reactive protein (hs-CRP).